Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 642063, 10 pages
http://dx.doi.org/10.1155/2014/642063
Review Article

Ablative Therapy for Esophageal Dysplasia and Early Malignancy: Focus on RFA

Roswell Park Cancer Institute Elm & Carlton Streets, Buffalo, NY 14263, USA

Received 27 February 2014; Accepted 7 July 2014; Published 21 July 2014

Academic Editor: Stephen Grobmyer

Copyright © 2014 Rebecca Tuttle et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ronkainen, P. Aro, T. Storskrubb et al., “Prevalence of Barrett's esophagus in the general population: an endoscopic study,” Gastroenterology, vol. 129, no. 6, pp. 1825–1831, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. N. J. Shaheen and J. E. Richter, “Barrett's oesophagus,” The Lancet, vol. 373, no. 9666, pp. 850–861, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. J. Spechler, P. Sharma, R. F. Souza, J. M. Inadomi, and N. J. Shaheen, “American gastroenterological association technical review on the management of Barrett's esophagus,” Gastroenterology, vol. 140, no. 3, pp. e18–e52, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. Survival rates for cancer of the esophagus by stage, 2013, http://www.cancer.org/cancer/esophaguscancer/detailedguide/esophagus-cancer-survival-rates.
  5. M. Singh, N. Gupta, S. Gaddam et al., “Practice patterns among U.S. gastroenterologists regarding endoscopic management of Barrett's esophagus,” Gastrointestinal Endoscopy, vol. 78, no. 5, pp. 689–695, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. F. Hulscher, J. W. Van Sandick, A. G. E. M. De Boer et al., “Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus,” The New England Journal of Medicine, vol. 347, no. 21, pp. 1662–1669, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. R. M. Levy, D. Trivedi, and J. D. Luketich, “Minimally Invasive Esophagectomy,” Surgical Clinics of North America, vol. 92, no. 5, pp. 1265–1285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Menon, T. Stafinski, H. Wu, D. Lau, and C. Wong, “Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy,” BMC Gastroenterology, vol. 10, article 111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Wu, Y.-M. Pan, T.-T. Wang, D.-J. Gao, and B. Hu, “Endotherapy versus surgery for early neoplasia in Barrett's esophagus: a meta-analysis,” Gastrointestinal Endoscopy, vol. 79, no. 2, pp. 233.e2–241.e2, 2014. View at Publisher · View at Google Scholar
  10. “The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002,” Gastrointestinal Endoscopy, vol. 58, no. 6, supplement, pp. S3–S43, 2003.
  11. A. Axon, M. D. Diebold, M. Fujino et al., “Update on the Paris classification of superficial neoplastic lesions in the digestive tract,” Endoscopy, vol. 37, no. 6, pp. 570–578, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Sharma, J. Dent, D. Armstrong et al., “The development and validation of an endoscopic grading system for barrett's esophagus: the prague C & M criteria,” Gastroenterology, vol. 131, no. 5, pp. 1392–1399, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. B. J. Reid, P. L. Blount, Z. Feng, and D. S. Levine, “Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia,” American Journal of Gastroenterology, vol. 95, no. 11, pp. 3089–3096, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. O. Pech, A. May, E. Günter, L. Gossner, and C. Ell, “The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus,” The American Journal of Gastroenterology, vol. 101, no. 10, pp. 2223–2229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. J. Schlemper, R. H. Riddell, Y. Kato et al., “The vienna classification of gastrointestinal epithelial neoplasia,” Gut, vol. 47, no. 2, pp. 251–255, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. B. F. Overholt, M. Panjehpour, and D. L. Halberg, “Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results,” Gastrointestinal Endoscopy, vol. 58, no. 2, pp. 183–188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. B. F. Overholt, C. J. Lightdale, K. K. Wang et al., “Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial,” Gastrointestinal Endoscopy, vol. 62, no. 4, pp. 488–498, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. B. F. Overholt, K. K. Wang, J. S. Burdick et al., “Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia,” Gastrointestinal Endoscopy, vol. 66, no. 3, pp. 460–468, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. B. J. Qumseya, W. David, and H. C. Wolfsen, “Photodynamic therapy for Barrett's esophagus and esophageal carcinoma,” Clinical Endoscopy, vol. 46, no. 1, pp. 30–37, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Shishkova, O. Kuznetsova, and T. Berezov, “Photodynamic therapy in gastroenterology,” Journal of Gastrointestinal Cancer, vol. 44, no. 3, pp. 251–259, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Yano, S. Hirohara, M. Obata et al., “Current states and future views in photodynamic therapy,” Journal of Photochemistry and Photobiology C: Photochemistry Reviews, vol. 12, no. 1, pp. 46–67, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Ertan, I. Zaheer, A. M. Correa, N. Thosani, and S. H. Blackmon, “Photodynamic therapy vs radiofrequency ablation for Barrett's dysplasia: efficacy, safety and cost-comparison,” World Journal of Gastroenterology, vol. 19, no. 41, pp. 7106–7113, 2013. View at Google Scholar
  23. T. Bright, D. I. Watson, W. Tam et al., “Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of barrett's esophagus in patients treated with antisecretory medication,” Digestive Diseases and Sciences, vol. 54, no. 12, pp. 2606–2611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Sie, T. Bright, M. Schoeman et al., “Argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus: late outcomes from two randomized trials,” Endoscopy, vol. 45, no. 11, pp. 859–865, 2013. View at Publisher · View at Google Scholar
  25. M. Hage, P. D. Siersema, H. van Dekken et al., “5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial,” Gut, vol. 53, no. 6, pp. 785–790, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. K. Ragunath, N. Krasner, V. S. Raman, M. T. Haqqani, C. J. Phillips, and I. Cheung, “Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness,” Scandinavian Journal of Gastroenterology, vol. 40, no. 7, pp. 750–758, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. C. J. Kelty, R. Ackroyd, N. J. Brown, T. J. Stephenson, C. J. Stoddard, and M. W. R. Reed, “Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation,” Alimentary Pharmacology and Therapeutics, vol. 20, no. 11-12, pp. 1289–1296, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. A. Ganz, B. F. Overholt, V. K. Sharma et al., “Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. multicenter registry,” Gastrointestinal Endoscopy, vol. 68, no. 1, pp. 35–40, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. N. J. Shaheen, P. Sharma, B. F. Overholt et al., “Radiofrequency ablation in Barrett's esophagus with dysplasia,” The New England Journal of Medicine, vol. 360, no. 22, pp. 2277–2288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. W. D. Lyday, F. S. Corbett, D. A. Kuperman et al., “Radiofrequency ablation of Barretts esophagus: outcomes of 429 patients from a multicenter community practice registry,” Endoscopy, vol. 42, no. 4, pp. 272–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. D. E. Fleischer and V. K. Sharma, “Endoscopic ablation of Barrett's esophagus using the Halo system,” Digestive Diseases, vol. 26, no. 4, pp. 280–284, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Ackroyd, W. Tam, M. Schoeman, P. G. Devitt, and D. I. Watson, “Prospective randomized controlled trial of argon plasma coagulation ablation vs. endoscopic surveillance of patients with Barrett's esophagus after antireflux surgery,” Gastrointestinal Endoscopy, vol. 59, no. 1, pp. 1–7, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S. E. A. Attwood, C. J. Lewis, S. Caplin, K. Hemming, and G. Armstrong, “Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus,” Clinical Gastroenterology and Hepatology, vol. 1, no. 4, pp. 258–263, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. B. D. Greenwald, J. A. Dumot, J. D. Horwhat, C. J. Lightdale, and J. A. Abrams, “Safety, tolerability, and efficacy of endoscopic low-pressure liquid nitrogen spray cryotherapy in the esophagus,” Diseases of the Esophagus, vol. 23, no. 1, pp. 13–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Gosain, K. Mercer, W. S. Twaddell, L. Uradomo, and B. D. Greenwald, “Liquid nitrogen spray cryotherapy in Barrett's esophagus with high-grade dysplasia: long-term results,” Gastrointestinal Endoscopy, vol. 78, no. 2, pp. 260–265, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. N. J. Shaheen, B. D. Greenwald, A. F. Peery et al., “Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia,” Gastrointestinal Endoscopy, vol. 71, no. 4, pp. 680–685, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. D. E. Fleischer, B. F. Overholt, V. K. Sharma et al., “Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up,” Gastrointestinal Endoscopy, vol. 68, no. 5, pp. 867–876, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. D. E. Fleischer, B. F. Overholt, V. K. Sharma et al., “Endoscopic radiofrequency ablation for Barretts esophagus: 5-year outcomes from a prospective multicenter trial,” Endoscopy, vol. 42, no. 10, pp. 781–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. B. D. Greenwald, J. A. Dumot, J. A. Abrams et al., “Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy,” Gastrointestinal Endoscopy, vol. 71, no. 4, pp. 686–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. K. D. Halsey, J. W. Chang, A. Waldt, and B. D. Greenwald, “Recurrent disease following endoscopic ablation of Barretts high-grade dysplasia with spray cryotherapy,” Endoscopy, vol. 43, no. 10, pp. 844–848, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Hur, S. E. Choi, J. H. Rubenstein et al., “The cost effectiveness of radiofrequency ablation for Barrett's esophagus,” Gastroenterology, vol. 143, no. 3, pp. 567–575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. H. Pohl, A. Sonnenberg, S. Strobel, A. Eckardt, and T. Rösch, “Endoscopic versus surgical therapy for early cancer in Barrett's esophagus: a decision analysis,” Gastrointestinal Endoscopy, vol. 70, no. 4, pp. 623–631, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. P. C. Boger, D. Turner, P. Roderick, and P. Patel, “A UK-based cost-utility analysis of radiofrequency ablation or oesophagectomy for the management of high-grade dysplasia in Barretts oesophagus,” Alimentary Pharmacology and Therapeutics, vol. 32, no. 11-12, pp. 1332–1342, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. F. G. I. van Vilsteren, K. N. Phoa, L. Alvarez Herrero et al., “Circumferential balloon-based radiofrequency ablation of Barrett's esophagus with dysplasia can be simplified, yet efficacy maintained, by omitting the cleaning phase,” Clinical Gastroenterology and Hepatology, vol. 11, no. 5, pp. 491–498, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. F. G. I. van Vilsteren and J. J. G. H. M. Bergman, “Endoscopic therapy using radiofrequency ablation for esophageal dysplasia and carcinoma in barrett's esophagus,” Gastrointestinal Endoscopy Clinics of North America, vol. 20, no. 1, pp. 55–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. H. P. Kim, W. J. Bulsiewicz, C. C. Cotton et al., “Focal endoscopic mucosal resection before radiofrequency ablation is equally effective and safe compared with radiofrequency ablation alone for the eradication of Barrett's esophagus with advanced neoplasia,” Gastrointestinal Endoscopy, vol. 76, no. 4, pp. 733–739, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. P. S. Dulai, H. Pohl, J. M. Levenick, S. R. Gordon, T. A. MacKenzie, and R. I. Rothstein, “Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study,” Gastrointestinal Endoscopy, vol. 77, no. 4, pp. 534–541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. L. A. Herrero, F. G. I. van Vilsteren, R. E. Pouw et al., “Endoscopic radiofrequency ablation combined with endoscopic resection for early neoplasia in Barrett's esophagus longer than 10 cm,” Gastrointestinal Endoscopy, vol. 73, no. 4, pp. 682–690, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. N. J. Shaheen, H. P. Kim, W. J. Bulsiewicz et al., “Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA registry,” Journal of Gastrointestinal Surgery, vol. 17, no. 1, pp. 21–29, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. K. O'Connell and V. Velanovich, “Effects of Nissen fundoplication on endoscopic endoluminal radiofrequency ablation of Barrett's esophagus,” Surgical Endoscopy and Other Interventional Techniques, vol. 25, no. 3, pp. 830–834, 2011. View at Publisher · View at Google Scholar · View at Scopus
  51. R. J. Haidry, J. M. Dunn, M. A. Butt et al., “Radiofrequency ablation and endoscopic mucosal resection for dysplastic Barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK national halo RFA registry,” Gastroenterology, vol. 145, no. 1, pp. 87–95, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. E. S. Orman, N. Li, and N. J. Shaheen, “Efficacy and durability of radiofrequency ablation for barrett's esophagus: systematic review and meta-analysis,” Clinical Gastroenterology and Hepatology, vol. 11, no. 10, pp. 1245–1255, 2013. View at Google Scholar
  53. W. J. Bulsiewicz, H. P. Kim, E. S. Dellon et al., “Safety and efficacy of endoscopic mucosal therapy with radiofrequency ablation for patients with neoplastic barrett's esophagus,” Clinical Gastroenterology and Hepatology, vol. 11, no. 6, pp. 636–642, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Beaumont, J. J. Gondrie, B. P. McMahon et al., “Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility,” Endoscopy, vol. 41, no. 1, pp. 2–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. G. J. M. Hemmink, L. A. Herrero, A. Bogte et al., “Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation,” European Journal of Gastroenterology & Hepatology, vol. 25, no. 9, pp. 1024–1032, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. F. G. I. van Vilsteren, L. Alvarez Herrero, R. E. Pouw et al., “Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study,” Endoscopy, vol. 45, no. 7, pp. 516–525, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. M. Gupta, P. G. Iyer, L. Lutzke et al., “Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection and radiofrequency ablation of Barrett's esophagus: results from a us multicenter consortium,” Gastroenterology, vol. 145, no. 1, pp. 79.e1–86.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. K. Krishnan, J. E. Pandolfino, P. J. Kahrilas, L. Keefer, L. Boris, and S. Komanduri, “Increased risk for persistent intestinal metaplasia in patients with Barrett's esophagus and uncontrolled reflux exposure before radiofrequency ablation,” Gastroenterology, vol. 143, no. 3, pp. 576–581, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. S. S. Zeki, R. Haidry, T. A. Graham et al., “Clonal selection and persistence in dysplastic Barrett's esophagus and intramucosal cancers after failed radiofrequency ablation,” The American Journal of Gastroenterology, vol. 108, no. 10, pp. 1584–1592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. E. S. Orman, H. P. Kim, W. J. Bulsiewicz et al., “Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's Esophagus with radiofrequency ablation,” American Journal of Gastroenterology, vol. 108, no. 2, pp. 187–195, 2013. View at Publisher · View at Google Scholar · View at Scopus
  61. R. J. Korst, S. Santana-Joseph, J. R. Rutledge et al., “Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus,” Journal of Thoracic and Cardiovascular Surgery, vol. 145, no. 6, pp. 1529–1534, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Akiyama, S. N. Marcus, and G. Triadafilopoulos, “Effective intra-esophageal acid control is associated with improved radiofrequency ablation outcomes in Barrett's esophagus,” Digestive Diseases and Sciences, vol. 57, no. 10, pp. 2625–2632, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. B. F. Overholt, P. J. Dean, J. A. Galanko, and C. J. Lightdale, “Does ablative therapy for barrett esophagus affect the depth of subsequent esophageal biopsy as compared with controls?” Journal of Clinical Gastroenterology, vol. 44, no. 10, pp. 676–681, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. N. J. Shaheen, A. F. Peery, B. F. Overholt et al., “Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus,” Gastrointestinal Endoscopy, vol. 72, no. 3, pp. 490.e1–496.e1, 2010. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Yuan, J. C. Hernandez, S. K. Ratuapli et al., “Prevalence of buried Barretts metaplasia in patients before and after radiofrequency ablation,” Endoscopy, vol. 44, no. 11, pp. 993–997, 2012. View at Publisher · View at Google Scholar · View at Scopus
  66. N. J. Shaheen, A. F. Peery, R. H. Hawes et al., “Quality of life following radiofrequency ablation of dysplastic Barretts esophagus,” Endoscopy, vol. 42, no. 10, pp. 790–799, 2010. View at Publisher · View at Google Scholar · View at Scopus